Clinical Trial Update: Intranasal Oxytocin for Frontotemporal Dementia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal oxytocin for frontotemporal dementia is in progress with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Frontotemporal Dementia | Phase 2 | Status: UNKNOWN